跳转至内容
Merck

1.02465

SAFC

氯化钙 二水合物

EMPROVE® API, Ph. Eur., BP, ChP, JP, USP

制药生产

别名:

Calcium dichloride

登录查看公司和协议定价


About This Item

经验公式(希尔记法):
CaCl2 · 2H2O
CAS号:
分子量:
147.01
MDL號碼:
分類程式碼代碼:
12352302
酶委員會索引編號:
600-075-5

agency

BP
ChP
JP
Ph. Eur.
USP

品質等級

產品線

EMPROVE® API

形狀

solid

效力

2630 mg/kg LD50, skin (Rat)

pH值

4.5-8.5 (20 °C, 50 g/L in H2O)

mp

176 °C (dec.) (lit.)

溶解度

soluble

應用

liquid formulation
ophthalmics
pharmaceutical
semi-solid formulation
solid formulation

儲存溫度

2-25°C

SMILES 字串

O.O.Cl[Ca]Cl

InChI

1S/Ca.2ClH.2H2O/h;2*1H;2*1H2/q+2;;;;/p-2

InChI 密鑰

LLSDKQJKOVVTOJ-UHFFFAOYSA-L

正在寻找类似产品? 访问 产品对比指南

一般說明

We provide industry-leading production know-how and comprehensive regulatory support for high-quality APIs, backed by nearly 200 years of experience. From a complete portfolio of innovative folates to custom synthesis, our customized and scalable solutions meet your specific production needs. As part of our EMPROVE® Program, our raw materials are offered with extensive documentation facilitating compliance of your pharma and biopharma product, full supply chain transparency and risk mitigation. Our SAFC® portfolio of high-quality products for biopharmaceutical and pharmaceutical formulation and production withstands strict quality control procedures and is produced according to applicable cGMP guidelines.

應用

Calcium chloride dihydrate is typically used in clinical nutrition and in infusion. Calcium Chloride dihydrate cryst. Emprove® API is manufactured according to ICH Q7 guidelines. A CEP and an US-DMF are available.

法律資訊

Emprove is a registered trademark of Merck KGaA, Darmstadt, Germany
SAFC is a registered trademark of Merck KGaA, Darmstadt, Germany

象形圖

Exclamation mark

訊號詞

Warning

危險聲明

危險分類

Eye Irrit. 2

儲存類別代碼

13 - Non Combustible Solids

水污染物質分類(WGK)

WGK 1

閃點(°F)

Not applicable

閃點(°C)

Not applicable


分析证书(COA)

输入产品批号来搜索 分析证书(COA) 。批号可以在产品标签上"批“ (Lot或Batch)字后找到。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

商品

Medicine for children poses unique formulation challenges compared to adults. Consider developmental physiology and age specifics when designing pharmaceuticals. Quality issues can severely impact patient safety. Therefore, excipient quality, supplier selection, and supply chain security are crucial, particularly for pediatric formulations.

相关内容

Developing formulations specifically for infants and children is increasingly important. To help you master these challenges effectively, we offer an extensive portfolio of well-established high-quality excipients and APIs for pediatric pharmaceutical formulations that are proven in practice.

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系技术服务部门